Artal Group’s CryoPort CYRX Stock Holding History

Artal Group’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-89,000	Closed	-$2.69M	–	143
2020 Q2	$2.69M	Buy	+89,000	New	+$1.98M	0.08%	120

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group's CYRX Position: Q3 2020 in Review

Artal Group sold out of CryoPort (CYRX) in Q3 2020, closing a stake of 89,000 shares — an estimated $2.69M sold.

Artal Group first reported a position in CYRX in Q2 2020 and held it in 1 quarter. The position peaked at $2.69M in Q2 2020. 171 funds tracked by Wall St. Rank hold CYRX as of Q3 2020.

Artal Group reported no remaining CryoPort position as of Q3 2020 after selling out during the quarter.
Artal Group sold 89,000 CryoPort shares in Q3 2020, an estimated $2.69M.
Artal Group first reported a position in CryoPort in Q2 2020 and held it in 1 quarter.
Artal Group's CryoPort position peaked at $2.69M in Q2 2020.
171 funds tracked by Wall St. Rank held CryoPort as of Q3 2020.

Based on Artal Group's 13F filing for Q3 2020, filed 13 Nov 2020.